Nektar Therapeutics (NKTR)
37.27
+0.02
(+0.05%)
USD |
NASDAQ |
Nov 13, 16:00
37.17
-0.10
(-0.27%)
After-Hours: 19:59
Nektar Therapeutics Market Cap : 1.272B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.271B |
| November 11, 2026 | 1.312B |
| November 10, 2026 | 1.289B |
| November 09, 2026 | 1.291B |
| November 06, 2026 | 1.272B |
| November 05, 2026 | 1.234B |
| November 04, 2026 | 1.313B |
| November 03, 2026 | 1.289B |
| November 02, 2026 | 1.261B |
| October 30, 2026 | 1.327B |
| October 29, 2026 | 1.337B |
| October 28, 2026 | 1.316B |
| October 27, 2026 | 1.296B |
| October 26, 2026 | 1.278B |
| October 23, 2026 | 1.270B |
| October 22, 2026 | 1.319B |
| October 21, 2026 | 1.306B |
| October 20, 2026 | 1.339B |
| October 19, 2026 | 1.251B |
| October 16, 2026 | 1.221B |
| October 15, 2026 | 1.287B |
| October 14, 2026 | 1.259B |
| October 13, 2026 | 1.294B |
| October 12, 2026 | 1.360B |
| October 09, 2026 | 1.405B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.392B |
| October 07, 2026 | 1.374B |
| October 06, 2026 | 1.362B |
| October 05, 2026 | 1.441B |
| October 02, 2026 | 1.487B |
| October 01, 2026 | 1.604B |
| September 30, 2026 | 2.066B |
| September 29, 2026 | 2.022B |
| September 28, 2026 | 2.061B |
| September 25, 2026 | 1.947B |
| September 24, 2026 | 2.027B |
| September 23, 2026 | 1.968B |
| September 22, 2026 | 2.081B |
| September 21, 2026 | 2.281B |
| September 18, 2026 | 2.290B |
| September 17, 2026 | 2.333B |
| September 16, 2026 | 2.300B |
| September 15, 2026 | 2.274B |
| September 14, 2026 | 2.338B |
| September 11, 2026 | 2.381B |
| September 10, 2026 | 2.411B |
| September 09, 2026 | 2.502B |
| September 08, 2026 | 2.575B |
| September 04, 2026 | 2.532B |
| September 03, 2026 | 2.606B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.360T |
| Arrowhead Pharmaceuticals, Inc. | 6.741B |
| Inovio Pharmaceuticals, Inc. | 158.11M |
| Ionis Pharmaceuticals, Inc. | 4.833B |
| Fortress Biotech, Inc. | 62.46M |
Market Cap Related Metrics
| PS Ratio | 16.56 |
| PEG Ratio | -0.0415 |
| Price to Book Value | 1.408 |
| Price | 37.27 |
| Earnings Yield | -17.97% |
| PEGY Ratio | -0.0415 |